Key takeaways
It is generally considered safe to take metformin and Zepbound (tirzepatide) together, as long as they are prescribed by your healthcare provider.
Taking metformin and Zepbound together may enhance their effects on weight and blood sugar levels. However, Zepbound usually has stronger weight loss effects than metformin.
Both Zepbound and metformin may cause digestive side effects, such as nausea, vomiting, and diarrhea.
Here's what we'll cover
Here's what we'll cover
Here's what we'll cover
Key takeaways
It is generally considered safe to take metformin and Zepbound (tirzepatide) together, as long as they are prescribed by your healthcare provider.
Taking metformin and Zepbound together may enhance their effects on weight and blood sugar levels. However, Zepbound usually has stronger weight loss effects than metformin.
Both Zepbound and metformin may cause digestive side effects, such as nausea, vomiting, and diarrhea.
Metformin and Zepbound (tirzepatide) are used for different purposes. Metformin is prescribed for diabetes, while Zepbound is used for weight loss. So, can you take metformin and Zepbound together? The short answer is yes, if prescribed by your healthcare provider.
Can you take metformin and Zepbound together?
Yes, it is generally considered safe to take metformin and Zepbound together, as long as it is done under the approval and guidance of a healthcare provider.
To start, let’s review the basics:
Metformin is a diabetes medication that lowers blood glucose by improving insulin sensitivity and decreasing how much glucose the liver makes.
Metformin is typically a first-line medication for the treatment of type 2 diabetes.
It is also associated with modest weight loss.
Tirzepatide is a dual GLP-1/GIP agonist that primarily works by slowing gastric emptying (i.e. the movement of food through the digestive tract) and encouraging more insulin release.
It is approved under the brand name Zepbound for weight loss and Mounjaro for type 2 diabetes.
For type 2 diabetes, healthcare providers may prescribe a GLP-1 medication, such as tirzepatide, if blood sugar targets are not reached after three months of metformin treatment.
Research suggests that adding tirzepatide to metformin therapy may enhance both weight loss and glycemic control. Additionally, there are studies that have found that combining these two medications may be more effective at lowering blood sugar levels and body weight than taking metformin alone.
Taking metformin and Zepbound together: what to know
Taking metformin and Zepbound together is generally considered safe, though a few considerations are worth reviewing.
Enhanced effects
On its own, metformin may lower hemoglobin A1C (HbA1C) by 1.0%–1.5%. However, some evidence shows tirzepatide may lower HbA1C by an additional ~2.0% when added to metformin.
Metformin may have modest weight loss effects when taken alone. But the SURPASS-2 study found that participants who used tirzepatide with metformin achieved substantial weight loss of up to 11.2 kilograms (24.7 lbs) over 40 weeks.
Potential for GI side effects
Metformin and Zepbound are both notorious for causing gastrointestinal (GI) side effects.
Zepbound’s most common side effects include nausea, diarrhea, vomiting, constipation, abdominal pain, and indigestion. They typically occur when you first start the medication and as your dosage increases, but they usually improve as your body adjusts to the medication.
Metformin’s GI side effects include diarrhea, nausea, vomiting, gas, indigestion, and abdominal discomfort. They usually improve after a few weeks as your body gets used to the medication. Taking metformin with food may also help.
Because both medications may cause digestive side effects, you may experience symptoms if you take them together. However, there is no clear evidence that metformin worsens or increases the likelihood of Zepbound side effects.
Risk of dehydration
Many people experience vomiting and diarrhea while taking Zepbound. If these side effects are persistent or severe, it can quickly lead to dehydration.
Dehydration can affect the kidneys' ability to function. This matters because metformin is mainly cleared from the body through the kidneys. If kidney function is impaired, it can be harder to clear metformin from the body, causing it to accumulate. This buildup can lead to life-threatening side effects, such as lactic acidosis.
Because of this risk, it is a good idea to contact your healthcare provider if you develop severe vomiting or diarrhea while taking these medications.
Dosing schedules
Taking metformin and Zepbound together should not change how either one is dosed. Zepbound dosing follows a titration schedule — meaning it is started at a low dose, and the dose is increased gradually over time. Your healthcare provider will also likely prescribe metformin at a low dose initially and increase it slowly based on how well you tolerate the medication.
Is metformin or Zepbound better?
If you are on a weight loss journey, Zepbound may be a better choice than metformin. But it is worth remembering that metformin and Zepbound are used for different reasons.
Both the American Gastroenterological Association and American Diabetes Association consider GLP-1 medications such as Zepbound a top choice for weight loss. In clinical trials, participants who took Zepbound lost an average of up to 20.9% of their body weight over 72 weeks of treatment.
If blood sugar control is your primary goal, metformin has been a first-line medication for type 2 diabetes for decades. It is generally considered a safe, effective, and inexpensive medication. However, tirzepatide may also support blood sugar control, as it has been shown to reduce HbA1C levels by up to 2.0% after 40 weeks of treatment in people with type 2 diabetes.
Here are some factors to consider if you are deciding which medication is right for you.
Zepbound may be the better choice if:
You are comfortable with injections. (Zepbound is a once-weekly injection, whereas metformin is a pill you take every day.)
Your primary goal is significant weight loss.
Metformin may be preferred if:
You don’t need to lose a lot of weight.
You are looking for a lower-cost medication.
You have a history of pancreatitis or severe GI problems, such as gastroparesis.
However, choosing between metformin and Zepbound is not always an either-or decision. Your healthcare provider may prescribe both medications to help manage blood sugar levels and weight loss. It is best to consult your healthcare provider if you are considering taking Zepbound and metformin together.
Zepbound vs. metformin: side-by-side comparison
Although Zepbound and metformin are used for different purposes, they can both support blood sugar control and weight loss. Here are some similarities and differences between the two medications.
| Zepbound (tirzepatide) | Metformin |
Drug class | Dual GLP-1/GIP agonist | Biguanide |
Standard form and dosage | Injection, 5 mg, 10 mg, or 15 mg once per week | Oral tablet, IR: 500 mg–2,550 mg per day; ER: 500 mg–2,000 mg per day |
FDA-approval//indications | Along with a reduced-calorie diet and increased exercise: - Weight loss in adults with obesity - Weight loss in adults with overweight and at least one weight-related health condition - Moderate to severe obstructive sleep apnea in adults with obesity | Along with a healthy diet and increased exercise: - Manage blood sugar levels in adults with type 2 diabetes |
Notable contraindications | - Personal or family history of thyroid cancer or a condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN2) - Allergy to tirzepatide or any other ingredients in Zepbound | - Severe kidney problems - Previous allergic reaction to metformin - Metabolic acidosis (a condition where too much acid builds up in the blood), including diabetic ketoacidosis |
Common side effects | - Nausea - Diarrhea - Vomiting - Constipation - Abdominal pain | - Diarrhea - Nausea - Vomiting - Gas |
Cost | $499–$1,086.37 (list price) or $299–$449 (cash price) | $8–$30 per month |
Bottom line
If you have been wondering whether you can take Zepbound and metformin together, the answer is yes — but this combination is only safe when approved by your healthcare provider. Here is a summary:
Metformin and Zepbound work through different mechanisms, but that difference is exactly why a healthcare provider may prescribe them together — combining them may support both blood sugar control and weight loss more than either medication alone.
Because both metformin and Zepbound can cause GI side effects, it is worth watching for symptoms like persistent vomiting or diarrhea, which can raise the risk of dehydration and, in turn, affect how the body clears metformin.
Ultimately, the right choice, whether that is metformin alone, Zepbound alone, or both together, comes down to your primary treatment goal, cost, and comfort with injections. A healthcare provider can help weigh these factors against your health history.
Frequently asked questions (FAQs)
Can you take metformin and Zepbound together for weight loss?
Yes, metformin and Zepbound are generally considered safe to take together for weight loss, as long as it is deemed appropriate by your healthcare provider. However, metformin is not FDA-approved for weight loss and typically has only modest effects on weight.
How much weight loss can you expect when you take metformin and Zepbound together?
It varies from person to person. In one study, participants who were already taking metformin and started tirzepatide lost an average of up to 11.2 kilograms (24.7 lbs) of body weight after 40 weeks of treatment.
Can you take metformin and Zepbound together for PCOS?
Maybe. A recent study found that combining metformin with low-dose Zepbound resulted in greater weight loss and improved reproductive and metabolic health. However, the study was small, as it only included 60 participants. More research is needed to determine the benefits of combining these medications for polycystic ovary syndrome (PCOS). A healthcare provider can discuss whether these medications are right for you.
Can you take weight loss injections while taking metformin?
Yes, it is usually considered safe to take weight loss injections, such as Zepbound, with metformin. Healthcare providers may prescribe weight loss injections alongside metformin for people with diabetes and overweight or obesity if weight loss is the primary treatment goal.
DISCLAIMER
If you have any medical questions or concerns, please talk to your healthcare provider. The articles on Health Guide are underpinned by peer-reviewed research and information drawn from medical societies and governmental agencies. However, they are not a substitute for professional medical advice, diagnosis, or treatment.
Zepbound Important Safety Information: Read more about serious warnings and safety info.
References
American Diabetes Association Professional Practice Committee. (2026). 8. Obesity and weight management for the prevention and treatment of type 2 diabetes: standards of care in diabetes-2026. Diabetes Care, 49(Suppl 1), S166–S182. doi: 10.2337/dc26-S008. Retrieved from https://diabetesjournals.org/care/article/49/Supplement_1/S166/163915/8-Obesity-and-Weight-Management-for-the-Prevention
Corcoran, C. & Jacobs, T. F. (2023). Metformin. StatPearls. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK518983/
Farzam, K. & Patel, P. (2024). Tirzepatide. StatPearls. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK585056/
Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. The New England Journal of Medicine, 385(6), 503–515. doi: 10.1056/NEJMoa2107519. Retrieved from https://www.nejm.org/doi/full/10.1056/NEJMoa2107519
Grunvald, E., Shah, R., Hernaez, R., et al. (2022). AGA Clinical Practice Guideline on Pharmacological Interventions for Adults With Obesity. Gastroenterology, 163(5), 1198–1225. Retrieved from https://www.gastrojournal.org/article/S0016-5085(22)01026-5/fulltext
Rosenstock, J., Wysham, C., Frías, J. P., et al. (2021). Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. Lancet (London, England), 398(10295), 143–155. doi: 10.1016/S0140-6736(21)01324-6. Retrieved from https://pubmed.ncbi.nlm.nih.gov/34186022/
Sanchez-Rangel, E. & Inzucchi, S. E. (2017). Metformin: clinical use in type 2 diabetes. Diabetologia, 60(9), 1586–1593. Retrieved from https://link.springer.com/article/10.1007/s00125-017-4336-x
Taylor, K. & Tripathi, A. K. (2025). Adult dehydration. StatPearls. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK555956/
U.S. Food and Drug Administration (FDA-a). (2026). Metformin tablet, extended release. Retrieved from https://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/27f603ec-25e6-4270-a7a3-34a64a76f7ef/spl-doc
U.S. Food and Drug Administration (FDA-b). (2026). Zepbound (tirzepatide) injection, for subcutaneous use: Full prescribing information. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/217806s042lbl.pdf
Xie, Z., Hu, J., Gu, H., et al. (2023). Comparison of the efficacy and safety of 10 glucagon-like peptide-1 receptor agonists as add-on to metformin in patients with type 2 diabetes: a systematic review. Frontiers in Endocrinology, 14, 1244432. doi: 10.3389/fendo.2023.1244432. Retrieved from https://pubmed.ncbi.nlm.nih.gov/37701904/
Yang, Z., Xu, Y., Du, H., et al. (2026). Short-Term Combined Treatment With Tirzepatide and Metformin for Overweight/Obese Chinese Women With Polycystic Ovary Syndrome: A Prospective, Open-Label, Randomised Controlled Trial. Diabetes, Obesity & Metabolism, 28(8), 7380–7392. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC13341338/














